S'abonner

Late-stage rehabilitation after anterior cruciate ligament reconstruction: a multicentre randomised controlled trial (PReP) - 23/02/24

Doi : 10.1016/j.rehab.2024.101827 
Daniel Niederer 1, 2, , Matthias Keller 3, Karl-Friedrich Schüttler 4, Christian Schoepp 5, Wolf Petersen 6, Raymond Best 7, Natalie Mengis 8, Julian Mehl 9, Matthias Krause 10, Sarah Jakob 11, Max Wießmeier 11, Lutz Vogt 11, Lucia Pinggera 7, Daniel Guenther 12, Andree Ellermann 7, Turgay Efe 3, David A. Groneberg 1, Michael Behringer 11, Thomas Stein 11, 13
1 Institute of Occupational, Social and Environmental Medicine, Goethe University Frankfurt, Germany 
2 Department of Movement and Training Science, Faculty of Humanities and Social Sciences, Institute of Sport Science, University of Wuppertal, Wuppertal, Germany 
3 OSINSTITUT ortho & sport, Munich, Germany 
4 Orthopaedicum Lich Giessen 
5 Department of Arthroscopic Surgery, Sports Traumatology and Sports Medicine, BG Klinikum Duisburg gGmbH, Germany 
6 Klinik für Orthopädie und Unfallchirurgie, Berlin, Germany 
7 Department of Orthopaedic and Trauma Surgery, Sportklinik Stuttgart, Stuttgart, Germany 
8 Arcus Sportklinik, Pforzheim, Germany 
9 Department for Orthopaedic Sports Medicine, Klinikum rechts der Isar, Munich, Germany 
10 Department of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany 
11 Department of Sport Science, Goethe University Frankfurt, Frankfurt am Main, Germany 
12 Department of Orthopaedic Surgery, Trauma Surgery, and Sports Medicine, Cologne Merheim Medical Center, Witten/Herdecke University, Germany 
13 SPORTHOLOGICUM Frankfurt - Center for Sport and Joint injuries, Frankfurt am Main, Germany 

Correspondence: PD Dr. Daniel Niederer, Department of Sports Medicine and Exercise Physiology, Goethe University Frankfurt, Frankfurt am Main, Germany. +49(0)69 798 24581Department of Sports Medicine and Exercise Physiology, Goethe University Frankfurt, Frankfurt am MainGermany
Sous presse. Manuscrit accepté. Disponible en ligne depuis le Friday 23 February 2024
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Trial registration German Clinical Trials Register (DRKS): registration number DRKS00015313 (DRKS, drks.de; 01. October 2018).

Highlights

We investigated a late-stage rehabilitation after an ACL reconstruction
The intervention led to slightly superior effects when compared to usual care
The small effects might justify the implementation of such rehabilitation

Le texte complet de cet article est disponible en PDF.

ABSTRACT

Background

At the completion of formal rehabilitation after anterior cruciate ligament reconstruction, functional capacity is only restored in a small proportion of affected individuals. Therefore, the end of formal rehabilitation is not the end of functional rehabilitation.

Objective

To compare adherence to and effectiveness of a late-stage rehabilitation programme with usual care after anterior cruciate ligament (ACL) reconstruction.

Methods

This prospective, double-blind, multicentre, parallel group, randomised controlled trial, included people aged 18 to 35 years after formal rehabilitation completion (mean [SD] 241 [92] days post-reconstruction). Participants were block-randomised to a 5-month neuromuscular performance intervention (Stop-X group) or usual care (medically prescribed standard physiotherapy, individual formal rehabilitation, home-exercises). All outcomes were measured once/month. Primary outcome was normalised knee separation distance on landing after drop jump. Baseline-adjusted linear mixed models were calculated.

Results

In total, 112 participants (Stop-X: 57; Usual care: 55,) were analysed. Initially, mean (SD) intervention frequency (units/week) was higher in the Stop-X than the Usual care group: 2.65 (0.96) versus 2.48 (1.14) units/week in the first and 2.28 (1.02) versus 2.14 (1.31) units/week in the second month. No between-group*time(*baseline)-differences were found for the primary outcome. Between-group*time-effects favoured the Stop-X-group at 2 months (fewer self-reported knee problems during sport, KOOS-SPORT) (estimate = 64.3, 95% CI 24.4-104.3 for the Stop-X), more confidence to return to sport (ACL-RSI) (62.4, 10.7-114.2), fewer pain-associated knee problems (KOOS-PAIN) (82.8, 36.0-129.6), improved everyday activity abilities (KOOS-ADL) (71.1, 6.4-135.7), and improved limb symmetry index in the front hop for distance at 3 and 4 months (0.34, 0.10-0.57; 0.31, 0.08-0.54). No between-group*time-effects occurred for kinesiophobia, symptom-associated knee problems or balance hops performance. At the end of the intervention, 79% of the Stop-X and 70% of the Usual care participants (p<0.05) had successfully returned to their pre-injury sport type and level.

Conclusions

The Stop-X intervention was slightly superior to usual care as part of late-stage rehabilitation after ACL-reconstruction. The small benefit might justify its use after formal rehabilitation completion.

Le texte complet de cet article est disponible en PDF.

Key words : Re-injury prevention, RTS, return to sports, RCT, ACL, Functional outcomes


Plan


© 2024  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.